Regeneron Pharma (REGN) PT Raised to $725 at BMO Capital
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $805.97 +1.00%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Regeneron Pharma (NASDAQ: REGN) to $725.00 (from $640.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- STAAR Surgical (STAA) PT Lowered to $28 at Jefferies
- Yeti Holdings Inc. (YETI) PT Raised to $56 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
